Amod Shivaji Patil
Amod Shivaji Patil has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Atul Arun Shirkhedkar
Department of Pharmaceutical Chemistry, R.C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra, India
2 shared publications - Saurabh B. Ganorkar
R.C.Patel Institute of Pharmaceutical Education and Research, Karwand Naka, Shirpur, 425405, Maharashtra, India
2 shared publications Suraj R. Chaudhari
Department of Pharmaceutical Chemistry R. C. Patel Institute of Pharmacy, Shirpur, India
2 shared publications- Suraj R. Chaudhari
Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, India
2 shared publications Ajinkya Joshi
Department of Pharmaceutical Chemistry R. C. Patel Institute of Pharmaceutical Education and Research Karwand Naka Shirpur Maharashtra- 425405 MS India
1 shared publication- Anand B. Mundada
Department of Pharmaceutical Chemistry, R.C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dhule, India
1 shared publication
Latest Publications
- 12 September 2025
- Published by Springer Nature in Journal of Applied Spectroscopy
- Vol. 92 (4) , 871-879
Parallel and Multimode UV-Visible Spectrophotometry Investigations for Topiroxostat
- 12 September 2025
- Published by Springer Nature in Journal of Applied Spectroscopy
- Vol. 92 (4) , 871-879
Parallel and Multimode UV-Visible Spectrophotometry Investigations for Topiroxostat
- 7 January 2025
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 20 (1) , 1-14
Advanced Normal-Phase HPTLC Profiling of Eltrombopag Olamine with Automated Development and Box-Behnken Optimizations
- 7 January 2025
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 20 (1) , 1-14
Advanced Normal-Phase HPTLC Profiling of Eltrombopag Olamine with Automated Development and Box-Behnken Optimizations
- Open Access
- 23 September 2024
- Published by I Publication Service
- Vol. 25 (1) , 1849-1856
A Novel and Sensitive Spectrophotometric Approach for Quantifying Vardenafil Hydrochloride Trihydrate in Tablets: Application to Dissolution Testing
Aims: To develop and validate a novel Zero-order Absorbance UV-Spectrophotometric method for the quantification of Vardenafil Hydrochloride Trihydrate in commercial tablets and its application for dissolution testing. Background: Erectile Dysfunction (ED) is a significant disorder affecting men's sexual health, with Vardenafil being a potent and selective inhibitor of phosphodiesterase type 5 (PDE5). Vardenafil is commonly used as an oral therapy for treating ED. Accurate and reliable methods for its quantification in pharmaceutical formulations and during dissolution tests are essential for quality control. Objective: To establish and validate a simple, accurate, precise, economical, and sensitive method for determining the concentration of Vardenafil hydrochloride trihydrate in commercial tablets and during dissolution tests using UV-Spectrophotometry. Method: A Zero-order Absorbance UV-Spectrophotometric approach was employed, utilizing 0.1N HCl as the solvent. The method was optimized to determine Vardenafil hydrochloride trihydrate within a linear range of 2-12 µg/mL, with a coefficient of correlation value greater than 0.99. The method was validated for accuracy, precision, sensitivity, and ruggedness according to ICH guidelines. Additionally, the method was applied for the quantification of Vardenafil hydrochloride trihydrate in dissolution tests. Result: The method successfully determined Vardenafil hydrochloride trihydrate concentration in commercial tablets, showing a % recovery between 99.85% and 100.07%. The % amount of drug estimated was in good agreement with the label claims. The method also allowed direct measurement of samples from the dissolution vessel without pH correction. Conclusion: The developed UV-Spectrophotometric method is a reliable, accurate, and cost-effective approach for quantifying Vardenafil hydrochloride trihydrate in commercial tablets and during dissolution tests. The method's validation as per ICH guidelines ensures its suitability for routine quality control. Other: This analytical approach provides the simple and economical technique for the analysis of Vardenafil hydrochloride in pharmaceutical formulation.
- 23 September 2024
- Published by I Publication Service
- Vol. 25 (1) , 1849-1856
Open AccessA Novel and Sensitive Spectrophotometric Approach for Quantifying Vardenafil Hydrochloride Trihydrate in Tablets: Application to Dissolution Testing
Aims: To develop and validate a novel Zero-order Absorbance UV-Spectrophotometric method for the quantification of Vardenafil Hydrochloride Trihydrate in commercial tablets and its application for dissolution testing. Background: Erectile Dysfunction (ED) is a significant disorder affecting men's sexual health, with Vardenafil being a potent and selective inhibitor of phosphodiesterase type 5 (PDE5). Vardenafil is commonly used as an oral therapy for treating ED. Accurate and reliable methods for its quantification in pharmaceutical formulations and during dissolution tests are essential for quality control. Objective: To establish and validate a simple, accurate, precise, economical, and sensitive method for determining the concentration of Vardenafil hydrochloride trihydrate in commercial tablets and during dissolution tests using UV-Spectrophotometry. Method: A Zero-order Absorbance UV-Spectrophotometric approach was employed, utilizing 0.1N HCl as the solvent. The method was optimized to determine Vardenafil hydrochloride trihydrate within a linear range of 2-12 µg/mL, with a coefficient of correlation value greater than 0.99. The method was validated for accuracy, precision, sensitivity, and ruggedness according to ICH guidelines. Additionally, the method was applied for the quantification of Vardenafil hydrochloride trihydrate in dissolution tests. Result: The method successfully determined Vardenafil hydrochloride trihydrate concentration in commercial tablets, showing a % recovery between 99.85% and 100.07%. The % amount of drug estimated was in good agreement with the label claims. The method also allowed direct measurement of samples from the dissolution vessel without pH correction. Conclusion: The developed UV-Spectrophotometric method is a reliable, accurate, and cost-effective approach for quantifying Vardenafil hydrochloride trihydrate in commercial tablets and during dissolution tests. The method's validation as per ICH guidelines ensures its suitability for routine quality control. Other: This analytical approach provides the simple and economical technique for the analysis of Vardenafil hydrochloride in pharmaceutical formulation.
- 16 February 2023
- Published by Springer Nature in JPC – Journal of Planar Chromatography – Modern TLC
- Vol. 36 (1) , 89-97
Normal- and reversed-phase high-performance thin-layer chromatography methods for the simultaneous determination of remogliflozin etabonate and metformin hydrochloride antidiabetic drugs in bulk and tablet formulation
- 16 February 2023
- Published by Springer Nature in JPC – Journal of Planar Chromatography – Modern TLC
- Vol. 36 (1) , 89-97
Normal- and reversed-phase high-performance thin-layer chromatography methods for the simultaneous determination of remogliflozin etabonate and metformin hydrochloride antidiabetic drugs in bulk and tablet formulation
- 7 September 2022
- Published by Elsevier in Analytical Biochemistry
- Vol. 657, 114888
A brief review on critical analytical aspects for quantification of ambroxol in biological samples
- 7 September 2022
- Published by Elsevier in Analytical Biochemistry
- Vol. 657, 114888
A brief review on critical analytical aspects for quantification of ambroxol in biological samples
- 13 May 2021
- Published by A and V Publications in Asian Journal of Pharmaceutical Analysis
- Vol. 11 (2) , 113-117
Application of Hydrotropic Solubilization Phenomenon for Estimation of Fenticonazole in Bulk and Vaginal capsules using UV-spectrophotometry Methods
The purpose of this study is to establish Novel Zero-order UV-Spectrophotometric - absorbance and Zero Order- Area under curve (AUC) methods for estimation of Fenticonazole Nitrate in bulk and vaginal capsules with the application of hydrotropic solubilization phenomenon. Fenticonazole Nitrate is an antifungal drug and it is completely insoluble in water. Pluronic F127 (10% w/v) solution was used as solvent for solubilization of Fenticonazole Nitrate. Maximum absorption for Fenticonazole Nitrate was found to be at wavelength 253nm when dissolved in Pluronic F127 (10% w/v) solution. The methods are based upon measurement of absorbance at 253nm and integration of area under curve for analysis of Fenticonazole Nitrate in the wavelength range of 242.2-261.6nm. The drug followed linearity in the concentration range of 8 - 40µg/mL with correlation coefficient value r2> 0.99 for both methods. The proposed methods were validated for accuracy (% recovery), precision, repeatability and ruggedness, as per ICH guidelines. The proposed methods were applied for qualitative and quantitative estimation of Fenticonazole Nitrate in vaginal capsules and results were found in good agreement with the label claimed. Developed methods can be used for routine analysis of Fenticonazole Nitrate in bulk and Vaginal Capsules.
- 13 May 2021
- Published by A and V Publications in Asian Journal of Pharmaceutical Analysis
- Vol. 11 (2) , 113-117
Application of Hydrotropic Solubilization Phenomenon for Estimation of Fenticonazole in Bulk and Vaginal capsules using UV-spectrophotometry Methods
The purpose of this study is to establish Novel Zero-order UV-Spectrophotometric - absorbance and Zero Order- Area under curve (AUC) methods for estimation of Fenticonazole Nitrate in bulk and vaginal capsules with the application of hydrotropic solubilization phenomenon. Fenticonazole Nitrate is an antifungal drug and it is completely insoluble in water. Pluronic F127 (10% w/v) solution was used as solvent for solubilization of Fenticonazole Nitrate. Maximum absorption for Fenticonazole Nitrate was found to be at wavelength 253nm when dissolved in Pluronic F127 (10% w/v) solution. The methods are based upon measurement of absorbance at 253nm and integration of area under curve for analysis of Fenticonazole Nitrate in the wavelength range of 242.2-261.6nm. The drug followed linearity in the concentration range of 8 - 40µg/mL with correlation coefficient value r2> 0.99 for both methods. The proposed methods were validated for accuracy (% recovery), precision, repeatability and ruggedness, as per ICH guidelines. The proposed methods were applied for qualitative and quantitative estimation of Fenticonazole Nitrate in vaginal capsules and results were found in good agreement with the label claimed. Developed methods can be used for routine analysis of Fenticonazole Nitrate in bulk and Vaginal Capsules.
- Open Access
- 5 January 2017
- Published by Modestum Ltd in Eurasian Journal of Analytical Chemistry
- Vol. 12 (5) , 443-458
Application of Quality by Design in the Development of HPTLC Method for Estimation of Anagliptin in Bulk and in-house Tablets
This paper comprehends systematic Quality by Design (QbD) based development of Normal-Phase High-Performance Thin-Layer Chromatography (NP-HPTLC) method for qualitative and quantitative estimation of anagliptin in bulk and in-house tablets. Chromatographic separation was executed out on...
- 5 January 2017
- Published by Modestum Ltd in Eurasian Journal of Analytical Chemistry
- Vol. 12 (5) , 443-458
Open AccessApplication of Quality by Design in the Development of HPTLC Method for Estimation of Anagliptin in Bulk and in-house Tablets
This paper comprehends systematic Quality by Design (QbD) based development of Normal-Phase High-Performance Thin-Layer Chromatography (NP-HPTLC) method for qualitative and quantitative estimation of anagliptin in bulk and in-house tablets. Chromatographic separation was executed out on...